Canadian Medical Cannabis Council

Canadian Medical Cannabis Council

April 05, 2016 07:00 ET

CMCC Welcomes RedeCan Pharm as Newest Member

TORONTO, ONTARIO--(Marketwired - April 5, 2016) - Today the Canadian Medical Cannabis Council (CMCC) announced that RedeCan Pharm has signed CMCC's Code of Ethics and joined CMCC as the association's newest member.

"RedeCan Pharm is very excited to join CMCC and work with other licensed producers committed to the highest standards of safety, quality, and patient access within Canada's medical cannabis industry," said Amy Thrower, Chief Operations Officer (COO) and ARPIC of RedeCan Pharm.

"We are thrilled to welcome RedeCan Pharm to CMCC," said CMCC Chair Mark Gobuty. "Every new member further galvanizes our ability to advocate for federal policies and industry business practices that are in the best interest of Canadian patients."

CMCC is a medical cannabis industry association representing licensed producers and other stakeholders who are committed to building long-term trust with patients by ensuring the highest standards of ethical behaviour across the entire medical cannabis supply chain, including the interactions between licensed producers and physicians. CMCC is pleased to welcome RedeCan Pharm to CMCC, and every new member further strengthens the association's voice as an ethical group of Licensed Producers.

About RedeCan Pharm

RedeCan Pharm is a family-owned and operated licensed commercial producer of medical cannabis located in the heart of the Niagara Peninsula. Owned by a small family team with more than 30 years of experience in agriculture, RedeCan Pharm aims to enrich the lives of customers with the best quality product alongside friendly support to assist in patients' medical needs. Customer service and satisfaction is a number one priority and RedeCan Pharm works relentlessly to ensure that all patients have a positive experience.

About the Canadian Medical Cannabis Council (CMCC)

The Canadian Medical Cannabis Council (CMCC) is an industry group representing stakeholders who are committed to advancing the highest standards of integrity, safety, quality, access, security and research within Canada's medical cannabis industry. All CMCC members are required to adhere to a Code of Ethics designed to serve patients' best interests.

Contact Information

  • or to speak with a representative
    of the Canadian Medical Cannabis Council,
    Marlo Taylor
    (416) 425-9143 ext. 11
    marlo.taylor@energipr.com